In addition, CD163-positive M2 TAM could induce angiogenesis through the pro-angiogenic factor CD147, a matrix metalloproteinase inducer, in a spectrum of patients ranging from MGUS to relapsed/refractory (R/R) MM [84]. This evidence concerns the gene CD163 and Miyoshi myopathy.